Bhargava M, Karak A K, Sharma S, Kochupillai V
Department of Pathology (Haematology Unit), All India Institute of Medical Sciences, Ansari Nagar, New Delhi.
Thymus. 1987;10(1-2):103-8. doi: 10.1007/978-94-009-3365-1_11.
Twenty-two of 35 patients with aplastic anaemia who received fetal liver infusion (FLI), responded to this treatment. Detailed review of bone marrow aspirates and biopsies was available in 17. There was a good correlation between clinical improvement and blood counts. The bone marrow cellularity increased to 48 percent in about 18 weeks with repopulation by both erythroid and myeloid cells. The erythroid response was predominant and the earliest to occur (1.5-61 weeks); it lasted for 7.5-100 weeks. Marked dyserythropoiesis was observed. Myeloid response occurred simultaneously in 45 percent of the responders; in the others it was delayed by 1.5 to 4 weeks. Significant dysmyelopoiesis with shift to the left, unrelated to infection, was seen 1.5 to 9.5 weeks after FLI lasting for 9-26 weeks in most cases. Megakaryocytic response either did not occur or was delayed, less marked and often transient.
35例接受胎肝输注(FLI)的再生障碍性贫血患者中有22例对该治疗有反应。17例患者有骨髓穿刺和活检的详细资料。临床改善与血细胞计数之间存在良好的相关性。骨髓细胞密度在约18周时增至48%,红系和髓系细胞均有再生。红系反应占主导且最早出现(1.5 - 61周);持续7.5 - 100周。观察到明显的红细胞生成异常。45%的有反应者同时出现髓系反应;其他患者则延迟1.5至4周。FLI后1.5至9.5周出现明显的髓系生成异常伴核左移,与感染无关,多数病例持续9 - 26周。巨核细胞反应要么未出现,要么延迟,不明显且通常短暂。